Equitas Small Finance Bank reported a net profit of Rs 116.42 crore in Q2 FY23, steeply higher than Rs 41.19 crore recorded in Q2 FY22.
High raw-material inflation, elevated freight expenses, and normalization in marketing spends have impacted margins of Indian pharma players over the past 12 months. However, some of these API/RM cost pressures have started abating in Q3CY22. Cipla, Sun, JB Pharma and Torrent remain IIFL Capital Services’ top-picks in the pharma sector owing to lowest risk to IIFL Capital Services’ margin and earnings estimates for these companies.
Axis Bank Ltd registered volume of 421.65 lakh shares by 10:45 IST on BSE, a 99.61 fold spurt over two-week average daily volume of 4.23 lakh shares
The seasonally adjusted S&P Global India Manufacturing Purchasing Managers Index (PMI) stood at 55.3 in October, up from 55.1 in September. The indices vary between 0 and 100, with a reading above 50 indicating an overall increase compared to the previous month, and below 50 an overall decrease. The indices are then seasonally adjusted. The latest figure was above its long-run average (53.7), indicating a […]

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.